Načítá se...
The inodilator levosimendan in repetitive doses in the treatment of advanced heart failure
Inotropes may be an appropriate response for some patients with advanced heart failure who remain highly symptomatic despite optimization of evidence-based therapy. These patients need to be supported waiting for a heart transplant or ventricular assist device, or may be candidates for inotropy as a...
Uloženo v:
| Vydáno v: | Eur Heart J Suppl |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Oxford University Press
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5932565/ https://ncbi.nlm.nih.gov/pubmed/29249905 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/sux004 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|